Value
3.0/10data confidence 67%| Component | Sub-score |
|---|---|
| P/S | 0.0 |
| EV/EBITDA | 0.0 |
| p ocf | 4.7 |
| Analyst target | 4.0 |
- ▸P/OCF: 23.9x (FFO proxy — REITs gated off P/E)
CTRE · Why this verdict
Why CareTrust REIT (CTRE) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.0/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Analysts see 23% upside to the consensus target from the current price, and recent news sentiment is positive — reflecting research community confidence in the business despite near-term earnings noise. Sentiment | Analyst targets hold and price gradually closes the gap toward the 23% upside over the next 12 months. | →Stable |
| CounterThe near-term take-profit level is only 6.7% above the current price, meaning the risk/reward at the next resistance level remains thin even if the longer-term analyst target is compelling. | ||
The business generates free cash flow equal to 288% of net income, posts 64% margins, and holds a perfect Piotroski F-Score of 9/9, placing it among the best-in-class names in its peer group on quality metrics. Quality | Cash generation and margins remain near current levels, sustaining the quality designation over the next four quarters. | →Stable |
| CounterDespite exceptional cash and quality metrics, four consecutive quarterly misses and a dividend yield safety warning indicate the payout may be at risk — an uncovered dividend would undermine the quality case for income-oriented investors. | ||
The company has missed earnings estimates in all four of the most recent reported quarters, with the oldest miss at -15.7% and the most recent narrowing sharply to -1.3%, suggesting analysts are gradually resetting expectations toward actual results. Earnings | The miss streak ends with the next quarterly report as the narrowing trajectory reaches breakeven and the company delivers an in-line or better result. | →Stable |
| CounterEven a four-quarter miss streak with narrowing gaps may persist if the business faces structural headwinds to meeting consensus targets, and each additional miss reinforces negative sentiment among institutional holders. | ||
RSI is near 20 (oversold), on-balance volume is rising (accumulation), and the stock remains above the 200-day moving average — a combination that creates a potential mean-reversion setup within an intact longer-term uptrend. Momentum | Price mean-reverts from the oversold reading and advances toward the analyst consensus target as technical conditions normalize. | →Stable |
| CounterShort interest of 10% and a put/call ratio of 2.44 indicate substantial bearish positioning that can overwhelm technical oversold signals, keeping the stock depressed even while the longer-term trend remains intact. | ||
Revenue and earnings growth are both running in the low single digits, placing this company near the bottom of its peer group on growth metrics and reducing the likelihood of a meaningful re-rating catalyst. Growth | Quarterly EPS exceeds $0.40 for 2 consecutive quarters, indicating an acceleration above the current $0.36 run rate. | →Stable |
| CounterBest-in-class cash conversion at 288% of net income means that even modest revenue growth generates disproportionate cash flow, which can support distributions and buybacks without requiring rapid top-line expansion. | ||
Analysts see 23% upside to the consensus target from the current price, and recent news sentiment is positive — reflecting research community confidence in the business despite near-term earnings noise.
→StableSentiment
- Expectation
- Analyst targets hold and price gradually closes the gap toward the 23% upside over the next 12 months.
CounterThe near-term take-profit level is only 6.7% above the current price, meaning the risk/reward at the next resistance level remains thin even if the longer-term analyst target is compelling.
The business generates free cash flow equal to 288% of net income, posts 64% margins, and holds a perfect Piotroski F-Score of 9/9, placing it among the best-in-class names in its peer group on quality metrics.
→StableQuality
- Expectation
- Cash generation and margins remain near current levels, sustaining the quality designation over the next four quarters.
CounterDespite exceptional cash and quality metrics, four consecutive quarterly misses and a dividend yield safety warning indicate the payout may be at risk — an uncovered dividend would undermine the quality case for income-oriented investors.
The company has missed earnings estimates in all four of the most recent reported quarters, with the oldest miss at -15.7% and the most recent narrowing sharply to -1.3%, suggesting analysts are gradually resetting expectations toward actual results.
→StableEarnings
- Expectation
- The miss streak ends with the next quarterly report as the narrowing trajectory reaches breakeven and the company delivers an in-line or better result.
CounterEven a four-quarter miss streak with narrowing gaps may persist if the business faces structural headwinds to meeting consensus targets, and each additional miss reinforces negative sentiment among institutional holders.
RSI is near 20 (oversold), on-balance volume is rising (accumulation), and the stock remains above the 200-day moving average — a combination that creates a potential mean-reversion setup within an intact longer-term uptrend.
→StableMomentum
- Expectation
- Price mean-reverts from the oversold reading and advances toward the analyst consensus target as technical conditions normalize.
CounterShort interest of 10% and a put/call ratio of 2.44 indicate substantial bearish positioning that can overwhelm technical oversold signals, keeping the stock depressed even while the longer-term trend remains intact.
Revenue and earnings growth are both running in the low single digits, placing this company near the bottom of its peer group on growth metrics and reducing the likelihood of a meaningful re-rating catalyst.
→StableGrowth
- Expectation
- Quarterly EPS exceeds $0.40 for 2 consecutive quarters, indicating an acceleration above the current $0.36 run rate.
CounterBest-in-class cash conversion at 288% of net income means that even modest revenue growth generates disproportionate cash flow, which can support distributions and buybacks without requiring rapid top-line expansion.
TrendMatrix Research · core thesis
Engine thesis — one sentence
A healthcare REIT with genuinely exceptional quality — 9/9 Piotroski F-Score, 64% margins, and free cash flow at 288% of net income — is overshadowed by four consecutive earnings misses, weak single-digit growth, a dividend yield safety warning, and heavy bearish options positioning (put/call ratio of 2.44), leaving the overall setup cautious despite strong analyst conviction and oversold technicals.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
7.9/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 3.1 |
| ROA | 3.2 |
| Gross margin | 10.0 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Current ratio | 7.3 |
| FCF quality | 10.0 |
| Moat | 6.0 |
| Rule of 40 | 9.5 |
| Piotroski F | 10.0 |
- ▸Strong margins: 64%
- ▸Excellent cash conversion: 288% FCF/NI
- ▸Rule of 40: 188 (elite)
- ▸Strong Piotroski F-Score: 9/9
Growth
3.1/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 3.3 |
| EPS growth | 3.0 |
Momentum
6.8/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.7 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 1.1 |
- ▸Overbought (RSI 86)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
5.4/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 6.2 |
| erm sentiment | 5.1 |
Insider
5.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.0 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
Peer rank
5.0/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 3.2 |
| quality rank | 8.1 |
| growth rank | 3.8 |
- ▸Best-in-class margins
Technical
3.2/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 0.1 |
| 52w position | 9.6 |
Risk (lower is worse)
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 4.8 |
| days to cover | 3.5 |
| volatility | 6.5 |
| put call | 10.0 |
| implied vol | 6.8 |
| beta | 8.3 |
| debt equity | 6.7 |
Catalyst
2.7/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 0.0 |
| earnings timing | 5.0 |
| surprise avg | 0.0 |
| dividend safety | 3.5 |
- ▸Earnings concerns: 0B/4M
- ▸Yield trap warning: high yield but unsafe
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (7)
- MOMENTUM:6.8>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:37d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-0.4=NEGATIVE
Warning (0)
none
Reward-to-Risk
-0.39
Upside
-5.6%
Downside
14.5%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityModerate — Balanced profile
Investment implication
The F-path SELL output reflects an overall score of 5.0 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Quality at 7.9) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-0.4=NEGATIVE) reinforce the read. Current asymmetry R:R is -0.39 — supplementary context, not the trigger for this path.
The strongest dimensions are Quality at 7.9, Momentum at 6.8, and Risk (lower is worse) at 6.7; the weakest are Catalyst at 2.7, Value at 3.0, and Growth at 3.1. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of -0.39 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Exceptional Quality Cash Conversion
Trip ifFree cash flow as a percentage of net income falls below 150% for 2 consecutive quarters, signaling deterioration in cash conversion quality.
- P2Four Quarter Earnings Miss Streak
Trip ifEPS surprise exceeds 3% for 2 consecutive quarters, confirming the miss streak has reversed.
- P3Oversold In Ongoing Uptrend
Trip ifPrice falls below the 200-day moving average for 2 consecutive weeks, breaking the longer-term uptrend.
- P4Strong Analyst Upside Conviction
Trip ifAnalyst upside to the consensus price target falls below 8% as targets are cut, indicating a meaningful reduction in conviction.
- P5Weak Growth Limits Rerating
Trip ifQuarterly EPS exceeds $0.40 for 2 consecutive quarters, indicating acceleration above the current $0.36 run rate.